ReviewFrontiers in public health2026
Artificial intelligence, autism care, and health equity: a public health narrative review.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autism spectrum disorder (ASD) is a common, lifelong neurodevelopmental condition whose recorded prevalence, diagnostic delays, and uneven distribution of specialist services create a growing public health challenge. Conventional screening and diagnostic pathways depend heavily on scarce specialist expertise, contributing to long waiting times and unequal access across income settings, regions, sex, ethnicity, language, and social position. This narrative review synthesises current applications of artificial intelligence (AI) and machine learning in autism screening, diagnostic support, intervention, and longitudinal monitoring, and reframes the evidence through a public health and health equity lens. We argue that AI's most important contribution to autism care is unlikely to lie in marginal improvements in classification accuracy alone. Rather, its potential value lies in expanding access, supporting task-sharing, shortening diagnostic pathways, enabling population-oriented screening, and reaching under-recognised groups such as girls and women, adults, ethnic and linguistic minorities, and populations in low-resource settings. At the same time, AI may create an equity paradox: technologies intended to reduce disparities may reproduce or amplify them if they are trained on non-representative data, deployed across a digital divide, or governed without adequate attention to privacy, accountability, and community trust. Whether AI narrows or widens autism-related health inequalities will depend on choices about data diversity, low-resource design, co-design with autistic communities, equity-sensitive evaluation, clinical integration, and proportionate regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.